文献速递颈动脉与弓上血管

TCAR与CEA院内结局比较:VQI注册研究

In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2019-06-18

基于VQI注册数据,比较2016年1月至2018年3月接受TCAR(1182例)与CEA(10797例)患者的院内结局。TCAR患者年龄更大、症状性比例更高且合并症更多,但未调整分析显示两组院内卒中/死亡(1.6% vs 1.4%;TCAR手术时间更短,颅神经损伤和术后住院>1天比例更低。

要点

  • TCAR患者合并症更多但院内卒中/死亡与CEA相当。
  • TCAR手术时间平均缩短33分钟,颅神经损伤更少。
  • 需更大样本和更长随访确认TCAR在颈动脉疾病中的角色。

核心结论

  • 尽管TCAR患者医疗风险更高,但TCAR与CEA的院内卒中/死亡率相似。

研究设计与样本

  • 基于SVS VQI TCAR监测项目注册和CEA数据库的回顾性比较研究,纳入2016年1月至2018年3月TCAR患者1182例和CEA患者10797例。

临床怎么用

  • 在高风险颈动脉狭窄患者中,TCAR可作为CEA的替代选择,院内卒中/死亡风险相似。

局限性

  • 需更大样本量和更长随访的进一步比较研究来确立TCAR在颅外颈动脉疾病管理中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Transcarotid artery revascularization (TCAR) with flow reversal offers a less invasive option for carotid revascularization in high-risk patients and has the lowest reported overall stroke rate for any prospective trial of carotid artery stenting. However, outcome comparisons between TCAR and carotid endarterectomy (CEA) are needed to confirm the safety of TCAR outside of highly selected patients and providers. METHODS: We compared in-hospital outcomes of patients undergoing TCAR and CEA from January 2016 to March 2018 using the Society for Vascular Surgery Vascular Quality Initiative TCAR Surveillance Project registry and the Society for Vascular Surgery Vascular Quality Initiative CEA database, respectively. The primary outcome was a composite of in-hospital stroke and death. RESULTS: A total of 1182 patients underwent TCAR compared with 10,797 patients who underwent CEA. Patients undergoing TCAR were older (median age, 74 vs 71 years; P < .001) and more likely to be symptomatic (32% vs 27%; P < .001); they also had more medical comorbidities, including coronary artery disease (55% vs 28%; P < .001), chronic heart failure (20% vs 11%; P < .001), chronic obstructive pulmonary disease (29% vs 23%; P < .001), and chronic kidney disease (39% vs 34%; P = .001). On unadjusted analysis, TCAR had similar rates of in-hospital stroke/death (1.6% vs 1.4%; P = .33) and stroke/death/myocardial infarction (MI; 2.5% vs 1.9%; P = .16) compared with CEA. There was no difference in rates of stroke (1.4% vs 1.2%; P = .68), in-hospital death (0.3% vs 0.3%; P = .88), 30-day death (0.9% vs 0.4%; P = .06), or MI (1.1% vs 0.6%; P = .11). However, on average, TCAR procedures were 33 minutes shorter than CEA (78 ± 33 minutes vs 111 ± 43 minutes; P < .001). Patients undergoing TCAR were also less likely to incur cranial nerve injuries (0.6% vs 1.8%; P < .001) and less likely to have a postoperative length of stay >1 day (27% vs 30%; P = .046). On adjusted analysis, there was no difference in terms of stroke/death (odds ratio, 1.3; 95% confidence interval, 0.8-2.2; P = .28), stroke/death/MI (odds ratio, 1.4; 95% confidence interval, 0.9-2.1, P = .18), or the individual outcomes. CONCLUSIONS: Despite a substantially higher medical risk in patients undergoing TCAR, in-hospital stroke/death rates were similar between TCAR and CEA. Further comparative studies with larger samples sizes and longer follow-up will be needed to establish the role of TCAR in extracranial carotid disease management.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Schermerhorn ML, Liang P, Dakour-Aridi H, et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2019. PMID: 31227410. doi:10.1016/j.jvs.2018.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。